Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Intellipharmaceutics Corp..

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Intellipharmaceutics Corp.
Canada Flag
Country
Country
Canada
Address
Address
Intellipharmaceutics International, Inc. 30 Worcester Road Toronto, Ontario Canada M9W 5X2
Telephone
Telephone
416-798-3001
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Company has granted Taro an exclusive license to market, sell and distribute in Canada, Desvenlafaxine Extended-release Tablets in the 50 mg and 100 mg strengths approved for sale in the Canadian market by the Pharmaceutical Drugs Directory (PDD) of Health Canada.


Lead Product(s): Desvenlafaxine Succinate

Therapeutic Area: Psychiatry/Psychology Product Name: Desvenlafaxine-Generic

Highest Development Status: ApprovedProduct Type: Small molecule

Recipient: Taro Pharmaceutical Industries

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement August 16, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY